Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Sondrel wins new design and supply contract

(Sharecast News) - Semiconductor company Sondrel said on Tuesday that it had won a new design and supply contract for a next-generation video processing chip with a total estimated value of $23.0m across the design, qualification and projected production life of the product. Sondrel said the complex chip was to be used for high-performance professional video streaming solutions, and that it has entered into a master agreement with the customer, with design work already commencing whilst the parties finalise negotiations.

The AIM-listed group stated the initial contract value was over $9.0m for the duration of the design and qualification phases, with the work to be fully funded by the customer. Chip production and supply were anticipated to start in 2026 and, subject to successful tapeout and qualification of prototypes, the contract was expected to generate roughly $14.0m in production revenues over 10-15 years, based on current customer forecasts.

Sondrel also reported that it has received four new orders for its design consulting services so far in 2024, generating combined revenues of $900,000 in the current financial year.

Chief executive Graham Curren said: "This is a substantial design and supply contract for Sondrel and a demonstration of the group's ability to provide the most complex engineering expertise required for these next-generation technologies.

"The collective new contracts for design consulting services are both an endorsement of our engineering capabilities by existing customers and, for the new ones, a positive indication of a recovery in the semiconductor market as wider macro volatility eases."

As of 1020 GMT, Sondrel shares were down 0.45% at 11.0p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Oxford Biomedica confident as it moves away from vaccine era
(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica reported stability in its core business on Monday, with a small increase in full-year core revenue for 2023, despite a 36% decrease in total revenue to £89.5m.
N Brown chairman Ron McMillan to retire
(Sharecast News) - N Brown said on Monday that chairman Ron McMillan will be retiring and stepping down from the board with effect from 30 April for personal reasons.
McCarthy out, Adshead in as Ultimate Products chair
(Sharecast News) - Ultimate Products, the parent of homeware brands including Salter and Beldray, announced a change in its leadership on Monday, with James 'Jim' McCarthy deciding to step down as non-executive chair from 31 July.
Digital 9 to make additional revolving credit facility repayment
(Sharecast News) - Infrastructure company Digital 9 Infrastructure announced a significant step towards strengthening its financial position on Monday, with the receipt of a deferred consideration payment of $25m (£20m) related to the sale of the Verne Global group, as announced on 15 March.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.